For the quarter ending 2026-03-31, BBNX had -$1,370K decrease in cash & cash equivalents over the period. -$25,209K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Change in fair value of warrant liabilities | - | 0 | 0 | 12,450 |
| Net loss | -21,895 | -13,466 | -14,209 | -45,525 |
| Depreciation expense | 585 | 538 | 385 | 650 |
| Provision for expected credit losses | - | 16 | 24 | 0 |
| Provision for net realizable value of inventory | - | - | - | 158 |
| Stock-based compensation expense | 5,406 | 4,303 | 4,478 | 7,603 |
| Net provision (recovery) for excess and obsolete inventory | -202 | 854 | 435 | 189 |
| Accretion of discount on short-term investments | - | -29 | -316 | -1,709 |
| Accretion of discount on long-term investments | - | - | 17 | -21 |
| Amortization of premium on long-term investments | - | 63 | - | - |
| Amortization of premium (discount) on short-term and long-term investments | 86 | - | - | - |
| Amortization of operating lease right-of-use asset | 402 | 397 | 298 | 607 |
| Loss on disposal of property and equipment | - | -31 | - | - |
| Accounts receivable | -1,368 | 5,595 | 168 | -601 |
| Inventories | 1,803 | 2,203 | 3,327 | 4,350 |
| Prepaid expenses and other current assets | -951 | 413 | 1,790 | 3,605 |
| Other long-term assets | 1 | -3 | 39 | -6 |
| Accounts payable | -3,333 | 527 | 1,100 | 471 |
| Accrued expenses and other current liabilities | -5,217 | 5,859 | 4,115 | -2,550 |
| Other long-term liabilities | 11 | 342 | 194 | 1,011 |
| Operating lease liability | -391 | -384 | -285 | -567 |
| Deferred revenue | 201 | 526 | 517 | 1,012 |
| Net cash used in operating activities | -23,832 | -8,627 | -8,729 | -33,569 |
| Purchases of short-term investments | - | 45,263 | 46,004 | 190,768 |
| Purchases of long-term investments | 24,784 | 176 | 14,228 | 31,069 |
| Proceeds from maturities and redemptions of short-term investments | 48,000 | 48,000 | 71,000 | 51,000 |
| Purchases of property and equipment | 1,377 | 1,903 | 1,282 | 2,112 |
| Net cash (used in) provided by investing activities | 21,839 | 658 | 9,486 | -172,949 |
| Proceeds from the issuance of common stock, net of underwriting discounts, commissions and issuance costs | - | -904 | 0 | 195,430 |
| Proceeds from the issuance of common stock from private placement, net of issuance costs | - | 0 | 0 | 15,591 |
| Proceeds from stock option exercises | 623 | 1,964 | 2,653 | 140 |
| Net cash provided by financing activities | 623 | 1,060 | 2,653 | 211,161 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -1,370 | -6,909 | 3,410 | 4,643 |
| Cash, cash equivalents and restricted cash at beginning of period | 31,676 | 38,585 | 30,532 | - |
| Cash, cash equivalents and restricted cash at end of period | 30,306 | 31,676 | 38,585 | - |